Vasorelaxant effect of euxanthone in the rat thoracic aorta

Vascular Pharmacology

Volumn 45, Issue 2, 2006, Pages 96-101

  Fang, Lian Hua ^a   Mu, Ya Mei ^a   Lin, Li Lin ^b   Xiao, Pei Gen ^b   Du, Guan Hua ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

Aorta; Calcium; Euxanthone; Protein kinase C; Vasorelaxation

Indexed keywords

CALCIUM ANTAGONIST; CALCIUM ION; EUXANTHONE; GLIBENCLAMIDE; INDOMETACIN; N(G) NITROARGININE; NORADRENALIN; PHORBOL DIBUTYRATE; POTASSIUM ION; PROPRANOLOL; PROTEIN KINASE C ACTIVATOR; UNCLASSIFIED DRUG; VASODILATOR AGENT; XANTHONE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; ENDOTHELIUM CELL; IC 50; INHIBITION KINETICS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; STEADY STATE; THORACIC AORTA; VASODILATATION;

ANIMALS; AORTA, THORACIC; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM; MALE; MOLECULAR STRUCTURE; RATS; RATS, WISTAR; VASODILATION; XANTHONES;

EID: 33748552635     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2006.03.011     Document Type: Article

References (21)

1. Brayden J.E. Membrane hyperpolarization is a mechanism of endothelium-dependent cerebral vasodilation. Am. J. Physiol. 259 3 Pt 2 (1990) H668-H673
2. Broekaert A., and Godfraind T. A comparison of the inhibitory effect of cinnarizine and papaverine on the noradrenaline and calcium-evoked contraction of isolated rabbit aorta and mesenteric arteries. Eur. J. Pharmacol. 53 3 (1979) 281-288
3. Castagna M., Takai Y., Kaibuchi K., Sano K., Kikkawa U., and Nishizuka Y. Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J. Biol. Chem. 257 (1982) 7847-7851
4. Li W.K., Chan C.L., Leung H.W., Yeung H.W., and Xiao P.G. Xanthones from Polygala caudate. Phytochemistry 51 (1999) 953-958
5. Librowski T., Czarnecki R., Czekaj T., and Marona H. New xanthone derivatives as potent anti-inflammatory agents. Medicina (Kaunas) 41 1 (2005) 54-58
6. Lin C.N., Hsieh H.K., Liou S.J., Ko H.H., Lin H.C., Chung M.I., Ko F.N., Liu H.W., and Teng C.M. Synthesis and antithrombotic effect of xanthone derivatives. J. Pharm. Pharmacol. 48 9 (1996) 887-890
7. Lin C.N., Liou S.J., Lee T.H., Chuang Y.C., and Won S.J. Xanthone derivatives as potential anti-cancer drugs. J. Pharm. Pharmacol. 48 5 (1996) 539-544
8. Lin L.L., Huang F., Chen S.B., Yang D.J., Chen S.L., Yang J.S., and Xiao P.G. Xanthones from the roots of Polygala caudata and their antioxidation and vasodilatation activities in vitro. Planta Med. 71 4 (2005) 372-375
9. Liu H.S., Lin C.N., and Won S.J. Antitumor effect of 2,6-di(2,3-epoxypropoxy)xanthone on tumor cell lines. Anticancer Res. 17 (1997) 1107-1114
10. Mak N.K., Li W.K., Zhang M., Wong R.N., Tai L.S., Yung K.K., and Leung H.W. Effects of euxanthone on neuronal differentiation. Life Sci. 66 4 (2000) 347-354
11. Mak N.K., Lung H.L., Wong R.N., Leung H.W., Tsang H.Y., and Leung K.N. Expression of protein kinase C isoforms in euxanthone-induced differentiation of neuroblastoma cells. Planta Med. 67 5 (2001) 400-405
12. Marona H. Synthesis and anticonvulsant effects of some aminoalkanolic derivatives of xanthone. Pharmazie 53 10 (1998) 672-676
13. Marona H., Gorka Z., and Szneler E. Aminoalkanolic derivatives of xanthone with potential antiepileptic activity. Pharmazie 53 4 (1998) 219-223
14. + sensitivity in norepinephrine-activated vascular smooth muscle. Am. J. Physiol. 259 1 Pt 2 (1990) H2-H8
15. Nishizuka Y. The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature 308 (1984) 693-698
16. Paoletti R., and Govonis S. Classification of calcium antagonists: proposal of the WHO committee. Pharmacol. Res. Commun. 19 2 (1987) 195-204
17. Saraiva L., Fresco P., Pinto E., Sousa E., Pinto M., and Goncalves J. Synthesis and in vivo modulatory activity of protein kinase C of xanthone derivatives. Bioorganic Med. Chem. 10 10 (2002) 3219-3227
18. Saraiva L., Fresco P., Pinto E., Sousa E., Pinto M., and Gonçalves J. Inhibition of protein kinase C by synthetic xanthone derivatives. Bioorganic Med. Chem. 11 7 (2003) 1215-1225
19. Savineau J.P., Marthan R., and Crevel H. Contraction of vascular smooth muscle induced by phorbol 12,13 dibutyrate in human and rat pulmonary arteries. Br. J. Pharmacol. 104 (1991) 639-644
20. Van Breemen C., Farinas B.R., Gerba P., and McNaughton E.D. Excitation-contraction coupling in rabbit aorta studied by the lanthanum method for measuring cellular calcium influx. Circ. Res. 30 1 (1972) 44-54
21. Vandier C., Le Guennec J.-Y., and Bedfer G. What are the signaling pathways used by norepinephrine to contract the artery? A demonstration using guinea pig aortic ring segments. Adv. Physiol. Educ. 26 (2002) 195-203